Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Verona Pharma (VRNA – Research Report) today and set a price target of $76.00. The company’s shares closed yesterday at $59.94.
VERONA, Italy :Atalanta thrashed lowly Hellas Verona 5-0 in Serie A on Saturday, with Italian striker Mateo Retegui scoring four times including a hat-trick before the break. Retegui, the league's ...
Sanofi S.A. Part Cert 0.02% €8.03M ...
ROME (AP) — Mateo Retegui scored four goals to lead Atalanta’s 5-0 demolition of Hellas Verona in Serie A on Saturday. The Italy striker took his league-leading tally to 20 goals for the ...
Fans don't think that the two colors in the Super Bowl 2025 logo — red and green — are a coincidence Skyler Caruso is a Writer and Reporter of PEOPLE Digital Entertainment. She joined PEOPLE ...
Tabuk Cement Co.-0.14% ر.س.1.29B Yamama Cement Co. 0.26% ر.س.7.72B Arabian Cement Co. 0.00% ر.س.2.75B Qassim Cement Co. 0.00% ر.س.5.95B Eastern ...
Sports Mole provides in-depth previews and predictions for every match from the biggest leagues and competitions in world football.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback